Quincy Bioscience is a biotechnology company based in Madison, Wisconsin, that focuses on the discovery, development and commercialization of novel technologies to support cognitive function and other normal health challenges such as mild memory loss associated with aging.
Quincy Bioscience is set apart by its cutting-edge applications of apoaequorin which is breaking new ground in protecting brain cells against aging. Apoaequorin is a calcium-binding protein originally discovered in jellyfish, now patented by Quincy Bioscience for use in a variety of products to support cognitive function. Apoaequorin is manufactured in a cGMP compliant facility.
Prevagen® is the company’s flagship consumer brand containing apoaequorin which has shown in published studies to be safe and effective. A landmark double-blind and placebo-controlled trial demonstrated Prevagen improved short-term memory, learning and delayed recall over 90 days.
As a result of the supplement’s safety and effectiveness, Prevagen is now the best-selling brain health supplement in chain pharmacies across America according to Nielsen data. In 2013, Quincy Bioscience was included in the Inc. 500|5000 list of the fastest growing private companies in the nation, for the second consecutive year.
Please visit www.quincybioscience.com for more information.